In Utero Magnesium Sulfate Exposure: Effects on Extremely-Low-Birth-Weight Infants (MgSO4)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01203501 |
Recruitment Status :
Completed
First Posted : September 16, 2010
Last Update Posted : September 26, 2017
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Infant, Newborn Infant, Low Birth Weight Infant, Small for Gestational Age Infant, Premature Intracranial Hemorrhages Leukomalacia, Periventricular Cerebral Palsy |
Study Type : | Observational |
Actual Enrollment : | 1339 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Official Title: | In Utero Magnesium Sulfate Exposure: Effects on Extremely-Low-Birth-Weight (ELBW) Infants |
Study Start Date : | July 1996 |
Actual Primary Completion Date : | June 1998 |
Actual Study Completion Date : | June 2000 |

- Incidence of Intraventricular Hemorrhage [ Time Frame: Hospital discharge 120 days of life ]
- Incidence of cerebral palsy [ Time Frame: 18-22 months corrected age ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | up to 14 Days (Child) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Probability Sample |
Inclusion Criteria:
- Infants born in NRN Centers with a birth weight of 401-1,500g
Exclusion Criteria:
- None

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01203501
United States, Alabama | |
University of Alabama at Birmingham | |
Birmingham, Alabama, United States, 35233 | |
United States, California | |
Stanford University | |
Palo Alto, California, United States, 94304 | |
United States, Connecticut | |
Yale University | |
New Haven, Connecticut, United States, 06504 | |
United States, District of Columbia | |
George Washington University | |
Washington, D.C., District of Columbia, United States, 20052 | |
United States, Florida | |
University of Miami | |
Miami, Florida, United States, 33136 | |
United States, Georgia | |
Emory University | |
Atlanta, Georgia, United States, 30303 | |
United States, Indiana | |
Indiana University | |
Indianapolis, Indiana, United States, 46202 | |
United States, Massachusetts | |
Harvard University | |
Cambridge, Massachusetts, United States, 02138 | |
United States, Michigan | |
Wayne State University | |
Detroit, Michigan, United States, 48201 | |
United States, New Mexico | |
University of New Mexico | |
Albuquerque, New Mexico, United States, 87131 | |
United States, Ohio | |
Cincinnati Children's Medical Center | |
Cincinnati, Ohio, United States, 45267 | |
Case Western Reserve University, Rainbow Babies and Children's Hospital | |
Cleveland, Ohio, United States, 44106 | |
United States, Rhode Island | |
Brown University, Women & Infants Hospital of Rhode Island | |
Providence, Rhode Island, United States, 02905 | |
United States, Tennessee | |
University of Tennessee | |
Memphis, Tennessee, United States, 38163 | |
United States, Texas | |
University of Texas Southwestern Medical Center at Dallas | |
Dallas, Texas, United States, 75235 |
Study Director: | James A. Lemons, MD | Indiana University | |
Principal Investigator: | Waldemar A. Carlo, MD | University of Alabama at Birmingham | |
Principal Investigator: | William Oh, MD | Brown University, Womens and Infants Hospital | |
Principal Investigator: | Avroy A. Fanaroff, MD | Case Western Reserve University, Rainbow Babies & Children's Hospital | |
Principal Investigator: | Edward F. Donovan, MD | Children's Hospital Medical Center, Cincinnati | |
Principal Investigator: | Barbara J. Stoll, MD | Emory University | |
Principal Investigator: | Ann R. Stark, MD | Brigham and Women's Hospital | |
Principal Investigator: | Charles R. Bauer, MD | University of Miami | |
Principal Investigator: | Lu-Ann Papile, MD | University of New Mexico | |
Principal Investigator: | David K. Stevenson, MD | Stanford University | |
Principal Investigator: | Sheldon B. Korones, MD | University of Tennessee | |
Principal Investigator: | Jon E. Tyson, MD MPH | University of Texas Southwestern Medical Center | |
Principal Investigator: | Seetha Shankaran, MD | Wayne State University | |
Principal Investigator: | Richard A. Ehrenkranz, MD | Yale University | |
Principal Investigator: | Raymond Bain, PhD | George Washington University |
NICHD Neonatal Research Network Extremely Low Birth Weight (ELBW) Prematurity Antenatal Magnesium sulfate |
Cerebral Palsy Intracranial Hemorrhages Leukomalacia, Periventricular Body Weight Hemorrhage Birth Weight Pathologic Processes Brain Damage, Chronic Brain Diseases |
Central Nervous System Diseases Nervous System Diseases Cerebrovascular Disorders Vascular Diseases Cardiovascular Diseases Encephalomalacia Infant, Premature, Diseases Infant, Newborn, Diseases |